Posts Tagged: Lidoderm
FTC revives complaint, files motion for stipulated order over pay-for-delay agreement for generic Lidoderm
On January 23rd, the Federal Trade Commission (FTC) announced that it had taken steps to resolve antitrust charges involving business activities employed by Irish/U.S. drugmaker …
FTC charges Endo Pharmaceuticals with antitrust violations for pay for delay patent settlements
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. – to eliminate the …
Pharma Update: News for April 2014
What follows below is a review of some of the pharma news stories that caught my attention during the month of April 2014. Supreme Court Denies Teva's Request …
